Science
Mechanism of Action
NONAPEPTIDE-13, also referenced in research as Nonapeptide-1 or Melanostatine-5, functions by antagonizing alpha-melanocyte-stimulating hormone (α-MSH). It competitively binds to the Melanocortin 1 Receptor (MC1R), thereby blocking the stimulation of melanin synthesis by α-MSH. Additionally, it directly reduces the activity of tyrosinase, a critical enzyme in the melanin production pathway. This dual action leads to decreased melanin deposition, effectively lightening hyperpigmentation and promoting a more even skin tone. Further benefits include stimulation of collagen synthesis for enhanced skin elasticity and a demonstrated soothing effect on irritated skin.
Research
Clinical Evidence
High confidence1.0-5.0%
Key findings
- 01 Optimal stability and efficacy are observed within the 1-5% concentration range, leading to a noticeable improvement in skin tone, a reduction in the visibility of age spots and dark areas, and an overall enhancement of radiance with reduced dullness.
- 02 Demonstrates effective inhibition of melanin-forming pathways in melanocytes, resulting in reduced melanin deposition and visibly brighter skin.
- 03 Clinical data indicates a reduction in melanin synthesis by approximately 33%, contributing to a significant reversal of hyperpigmentation and equalization of skin tone within 28 days of consistent application.
Transparency
Dusting Analysis
While some forms of NONAPEPTIDE-13 (e.g., powder for daily use at 0.0001%) demonstrate efficacy at very low concentrations, for optimal skin brightening and dark spot reduction in solution-based formulations, concentrations typically between 1.0% and 5.0% are recommended. Products formulated with solution-based NONAPEPTIDE-13 below 1.0% may not deliver the full spectrum of its clinically demonstrated benefits for comprehensive skin tone improvement.
The Formula
Formulation
Stability
Optimal stability and efficacy are best maintained within a pH range of 5.0-7.0, with a recommended formulation pH range of 4.0-7.0. Comprehensive stability testing across varying temperatures and conditions is essential to ensure consistent effectiveness over time.
Conflicts
- Formaldehyde-releasing preservatives
Safety
Safety Profile
NONAPEPTIDE-13 is generally well-tolerated for topical cosmetic applications, demonstrating a low risk of irritation or adverse reactions across most skin types, including sensitive skin. It holds an EWG VERIFIED status, signifying no obvious concerns regarding cancer, developmental & reproductive toxicity, or allergies & immunotoxicity. The maximum existing dosage for leave-on products in the China Inventory (2021) is 2.0%. A specific safety assessment by CIR, SCCS, or FDA is not publicly available in the current research data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
NONAPEPTIDE-13 is a valuable biomimetic peptide, offering precise melanin regulation for significant skin brightening, hyperpigmentation reduction, and anti-aging benefits, making it suitable for all skin types with a low risk of irritation.
Related
Similar Ingredients
Finding similar ingredients…